Jung Gi Min

Jung Gi Min

Auto-generated profile, based on publicly available information

Jung Gi Min

Stanford University School of Medicine, Stanford, California, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2021 in Trauma Surgery & Acute Care Open
Verified
Journal Article
Open access
PDF file
PCPeter I Cha
Peter I Cha
JMJung Gi Min
Jung Gi Min
APAdvait Patil
Advait Patil
JCJeff Choi
Jeff Choi
NKNishita N Kothary
Nishita N Kothary
JFJoseph D Forrester
Joseph D Forrester
Background There is a critical need for non-narcotic analgesic adjuncts in the treatment of thoracic pain. We evaluated the efficacy of intercostal cryoneurolysis as an analgesic adjunct for chest wall pain, specifically addressing the applicability of intercostal cryoneurolysis for pain control after chest wall trauma. Methods A systematic review was performed through searches of PubMed, EMBASE, and the Cochrane Library. We included studies involving patients of all ages that evaluated the efficacy of intercostal cryoneurolysis as a pain adjunct for chest wall pathology. Quantitative and qualitative synthesis was performed. Results Twenty-three studies including 570 patients undergoing cryoneurolysis met eligibility criteria for quantitative analysis. Five subgroups of patients treated with intercostal cryoneurolysis were identified: pectus excavatum (nine studies); thoracotomy (eight studies); post-thoracotomy pain syndrome (three studies); malignant chest wall pain (two studies); and traumatic rib fractures (one study). There is overall low-quality evidence supporting intercostal cryoneurolysis as an analgesic adjunct for chest wall pain. A majority of studies demonstrated decreased inpatient narcotic use with intercostal cryoneurolysis compared with conventional pain modalities. Intercostal cryoneurolysis may also lead to decreased hospital length of stay. The procedure did not definitively increase operative time, and risk of complications was low. Conclusions Given the favorable risk-to-benefit profile, both percutaneous and thoracoscopic intercostal cryoneurolysis may serve as a worthwhile analgesic adjunct in trauma patients with rib fractures who have failed conventional medical management. However, further prospective studies are needed to improve quality of evidence. Level of evidence Level IV systematic reviews and meta-analyses.

24 March 2020 in The Cleft Palate Craniofacial Journal
Verified
Journal Article
Closed access
PDF file
JMJung Gi Min
Jung Gi Min
RKRohit K. Khosla
Rohit K. Khosla
CCCatherine Curtin
Catherine Curtin
Objective: To increase access to high-quality and multiregional databases in global epidemiology of cleft surgeries through partnership with an NGO. Design: The study retrospectively analyzes 34 801 primary palate surgeries in 70+ countries from the 2016 electronic health records of an non-governmental organization (NGO). The study also utilizes the Kids’ Inpatient Database to compare the epidemiology of primary cleft palate surgeries in the United States. Participants: Patient records of those undergoing primary cleft palate surgeries only. Main Outcome Measures: Region, age, sex, type of cleft, laterality of cleft. Results: Key findings show that average age of those receiving primary cleft palate surgery in the low- and middle-income countries (LMICs) was 1.95 years. The distribution of males and females receiving surgery corresponds to the US national data. More hard cleft palates were on the left side (66.18%) than the right side (33.82%), independent of gender and region. Conclusions: Databases from an established NGO can be used to enhance our understanding of the disease characteristics in these regions. By increasing the information available regarding cleft surgeries in the LMIC, we hope to increase awareness of the similarities and differences in surgeries across various regions, as part of an effort to inform the goals set by Global Surgery 2030 initiative by the Lancet Commission.

1 January 2026 in Journal of Cardiac Surgery
Verified
Journal Article
Open access
SWSongnan Wang
Songnan Wang
NTNika Samadzadeh Tabrizi
Nika Samadzadeh Tabrizi
EWElizabeth Y. Wang
Elizabeth Y. Wang
JMJung Min
Jung Min
MMMaurice Musoni
Maurice Musoni
YLYihan Lin
Yihan Lin
Objective: Health‐related quality of life (HRQoL) assessment is pivotal for advancing sustainable global cardiac surgery. However, the use and applicability of HRQoL instruments in low‐ and lower‐middle‐income countries (LI‐LMICs) remain poorly characterized. Methods: A systematic review of studies assessing HRQoL among patients undergoing cardiac surgery in LI‐LMICs was performed using PubMed/MEDLINE, Embase, Scopus, Global Index Medicus, and CABI Global Health. Primary outcomes included the prevalence and types of HRQoL instruments adopted. A meta‐analysis of pooled HRQoL scores was performed to examine the impact of cardiac surgery. Results: Thirty‐eight studies comprising 12,397 patients from seven countries were identified. Most studies were conducted in Iran (21, 55%) or India (7, 18%); only one study (2.6%) originated from a LIC (Rwanda). Generic HRQoL instruments predominated (28/41, 68%), most commonly the Short Form‐12/36 (SF‐12/36; 20, 49%) and the World Health Organization Quality of Life (WHOQOL) or WHOQOL Brief (WHOQOL‐BREF) (4, 9.8%). Cardiac surgery was associated with significant postoperative improvements in HRQoL, including physical (standardized mean difference [SMD]:1.17; 95% CI 0.83–1.51; p < 0.0001) and mental (0.78; 95% CI 0.47–1.09; p < 0.0001) component scores measured by SF‐12/36. Significant improvements were also observed across WHOQOL domains: physical (0.84; 95% CI 0.51–1.08; p < 0.0001), psychological (0.54; 95% CI 0.32–0.75; p < 0.0001), social (0.33; 95% CI 0.12–0.53; p = 0.002), and environmental (0.34; 95% CI 0.14–0.55; p = 0.001). Conclusions: The use of validated and culturally appropriate HRQoL instruments is crucial for assessing patient‐centered outcomes in global cardiac surgery. Although significant improvements in HRQoL following cardiac surgery were observed in LI‐LMICs, fewer than 9% of LI‐LMICs were represented in the existing literature, highlighting a substantial gap in outcome assessment of global cardiac surgery.